The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Genetic variants of TCF7L2 and AXIN2 predict gender and tumor location-dependent clinical outcome in FIRE-3 trial: A validation study.
Yan Ning
No relevant relationships to disclose
Sebastian Stintzing
No relevant relationships to disclose
Volker Heinemann
No relevant relationships to disclose
Wu Zhang
No relevant relationships to disclose
Dongyun Yang
No relevant relationships to disclose
Yu Sunakawa
No relevant relationships to disclose
Stefan Stremitzer
No relevant relationships to disclose
Ana Sebio
No relevant relationships to disclose
Shinichi Yamauchi
No relevant relationships to disclose
Satoshi Matsusaka
No relevant relationships to disclose
Rita Elkhoueiry
No relevant relationships to disclose
Afsaneh Barzi
No relevant relationships to disclose
Anthony B. El-Khoueiry
No relevant relationships to disclose
Heinz-Josef Lenz
No relevant relationships to disclose